التفاصيل البيبلوغرافية
| العنوان: |
Emerging SARS-CoV-2 Variants in Uganda in the Era of COVID-19 Vaccination. |
| المؤلفون: |
Bbosa, Nicholas, Kiiza, Ronald, Ssekagiri, Alfred, Namagembe, Hamidah Suubi, Nabirye, Stella Esther, Kabuuka, Danstan, Rwankindo, Cleophous, Kisakye, Annet, Woldemariam, Yonas T., Kusemererwa, Sylvia, Ongaria, Terry A., Kakande, Ayoub, Abaasa, Andrew, Kimbugwe, Geofrey, Bosa, Henry Kyobe, Driwale, Alfred, Mwenda, Jason M., Worwui, Archibald K., Humphreys, James, Cohuet, Sandra |
| المصدر: |
Viruses (1999-4915); Dec2024, Vol. 16 Issue 12, p1860, 11p |
| مصطلحات موضوعية: |
SARS-CoV-2 Omicron variant, SARS-CoV-2, COVID-19 pandemic, VACCINE effectiveness, VACCINATION status |
| مستخلص: |
The emergence of SARS-CoV-2 variants has heightened concerns about vaccine efficacy, posing challenges in controlling the spread of COVID-19. As part of the COVID-19 Vaccine Effectiveness and Variants (COVVAR) study in Uganda, this study aimed to genotype and characterize SARS-CoV-2 variants in patients with COVID-19-like symptoms who tested positive on a real-time PCR. Amplicon deep sequencing was performed on 163 oropharyngeal/nasopharyngeal swabs collected from symptomatic patients. Genome assembly, lineage classification and phylogenetic analysis was performed using the Edge Bioinformatics pipeline version 2.4.0, Pangolin version 4.3.1 and iqtree version 2.3.6 software respectively. Of the 163 deep sequences analyzed between April 2023 and March 2024, the most common were XBB.1 lineages and sublineages (113, 69.3%), followed by JN.1* (12, 7.4%), XBB.2* (11, 6.7%) and FL* (11, 6.7%), EG* (7, 4.3%), others (BQ.1.1, FY.4.1, FY.4.1.2, GY.2.1, HK.27.1) (5, 3.1%) and CM* (4, 2.5%). XBB.1* dominated from April to July 2023; thereafter, other variants, including JN.1* were increasingly detected. There was no statistically significant association between vaccine status and lineage assignment (Fisher's exact test, p-value = 0.994). Our findings showed that the Omicron variant, specifically the XBB.1* lineage, was the dominant circulating virus. However, the emergence of the JN.1 variant that exhibits a significant spike protein mutation profile could impact COVID-19 transmission in Uganda. [ABSTRACT FROM AUTHOR] |
|
Copyright of Viruses (1999-4915) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder